AMLP
Alerian MLP ETF
Alerian MLP ETF historical holders
total: 2
Muhlenkamp & Co Alerian MLP ETF transactions over time
- Total transactions:
- 27
- New positions:
- 2
- Sold out:
- 1
- Added:
- 15
- Reduced:
- 9
- Held since:
- 2018 Q1
- Held for:
- 30 quarters
- Latest activity:
- 2026 Q1
Ronald Muhlenkamp has been an institutional investor in Alerian MLP ETF (AMLP) since 2015 Q4. According to 2026 Q1 report, Ronald Muhlenkamp holds 150,615 shares with a market value of roughly $7.93M representing 2.09% of their equity portfolio. The fund/company first acquired AMLP in 2015 Q4, initially purchasing 831,070 shares. Ronald Muhlenkamp later completely sold out the position and reinvested in AMLP again in 2018 Q1. Since the initial investment, Muhlenkamp & Co has made 26 more transactions in this position.
Does Ronald Muhlenkamp still hold AMLP?
Yes, Ronald Muhlenkamp continues to hold Alerian MLP ETF (AMLP). According to their 2026 Q1 report, they maintain a position of 150,615 shares valued at approximately $7.93M, representing 2.09% of their equity portfolio.
When did Ronald Muhlenkamp first invest in AMLP?
Ronald Muhlenkamp first invested in Alerian MLP ETF (AMLP) in 2015 Q4 at the reported quarter-end price of $12.05 per share, acquiring 831,070 shares in their initial purchase.
What is Ronald Muhlenkamp's average cost basis for AMLP?
Based on historical transaction data, Ronald Muhlenkamp's estimated cost basis for Alerian MLP ETF (AMLP) is approximately $10.47 per share. This represents their average reported price* across all buy transactions.
Has Ronald Muhlenkamp reinvested in AMLP after selling?
Yes, Ronald Muhlenkamp has shown renewed interest in Alerian MLP ETF (AMLP). After completely selling their position, they reinitiated an investment in 2018 Q1, demonstrating continued conviction in this ticker.
Estimated cost basis*
- Weighted AVG buy price:
- $10.47
- Weighted AVG sell price:
- $27.31
AMLP transactions history by Muhlenkamp & Co
27 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q1
|
2.09%
|
150,615
|
$52.64
|
$7,928,374
|
-14.57% (-25,686)
|
-0.36%
|
|
2025 Q4
|
2.23%
|
176,301
|
$47.02
|
$8,289,673
|
-0.24% (-420)
|
-0.01%
|
|
2025 Q3
|
2.25%
|
176,721
|
$46.93
|
$8,293,497
|
+0.01% (+9)
|
+0%
|
|
2025 Q2
|
2.69%
|
176,712
|
$48.86
|
$8,634,160
|
+0.00% (+8)
|
+0%
|
|
2025 Q1
|
3.00%
|
176,704
|
$51.94
|
$9,178,015
|
+0.91% (+1,595)
|
+0.03%
|
|
2024 Q4
|
2.56%
|
175,109
|
$48.16
|
$8,433,238
|
+0.00% (+8)
|
+0%
|
|
2024 Q3
|
2.53%
|
175,101
|
$47.13
|
$8,252,512
|
+0.31% (+546)
|
+0.01%
|
|
2023 Q2
|
2.43%
|
174,555
|
$39.21
|
$6,844,302
|
-38.61% (-109,762)
|
-1.82%
|
|
2022 Q4
|
4.59%
|
284,317
|
$38.07
|
$10,823,948
|
+0.09% (+260)
|
+0%
|
|
2022 Q3
|
4.64%
|
284,057
|
$36.56
|
$10,385,000
|
+1.05% (+2,957)
|
+0.05%
|
|
2022 Q2
|
4.53%
|
$34.45
|
-0.21% (-593)
|
|||
|
2022 Q1
|
3.76%
|
$38.30
|
+0.53% (+1,493)
|
|||
|
2021 Q4
|
3.20%
|
$32.74
|
-0.08% (-236)
|
|||
|
2021 Q3
|
3.59%
|
$33.33
|
-0.16% (-451)
|
|||
|
2021 Q2
|
3.75%
|
$36.41
|
+0.16% (+451)
|
|||
|
2021 Q1
|
3.36%
|
$32.43
|
+8.83% (+22,744)
|
|||
|
2020 Q4
|
2.66%
|
$25.66
|
+1.15% (+2,936)
|
|||
|
2020 Q3
|
2.64%
|
$19.98
|
+0.90% (+2,269)
|
|||
|
2020 Q2
|
3.33%
|
$24.68
|
-73.18% (-688,942)
|
|||
|
2019 Q4
|
3.50%
|
$8.50
|
+20.45% (+159,828)
|
|||
|
2019 Q3
|
3.48%
|
$9.14
|
+0.06% (+438)
|
|||
|
2019 Q2
|
3.74%
|
$9.85
|
-0.33% (-2,590)
|
|||
|
2019 Q1
|
3.72%
|
$10.03
|
+333.09% (+602,784)
|
|||
|
2018 Q3
|
0.83%
|
$10.68
|
-3.61% (-6,773)
|
|||
|
2018 Q1
|
0.64%
|
$9.37
|
new
|
|||
|
2016 Q1
|
0.00%
|
$12.05
|
-100% (-831,070)
|
|||
|
2015 Q4
|
3.16%
|
$12.05
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.